Exercise or conversion by Frank Williams of 9060 shares of Evolent Health subject to Rule 16b-3
EVH Stock | USD 9.77 0.21 2.10% |
Under 62% of Evolent Health's investor base is looking to short. The analysis of overall sentiment of trading Evolent Health stock suggests that many investors are alarmed at this time. Evolent Health's investing sentiment shows overall attitude of investors towards Evolent Health.
Filed transaction by Evolent Health Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
Read at macroaxis.com
Evolent Health Fundamental Analysis
We analyze Evolent Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evolent Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evolent Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
Evolent Health is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Evolent Health Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Evolent Health stock to make a market-neutral strategy. Peer analysis of Evolent Health could also be used in its relative valuation, which is a method of valuing Evolent Health by comparing valuation metrics with similar companies.
Peers
Evolent Health Related Equities
NRC | National Research | 8.59 | ||||
CERT | Certara | 4.19 | ||||
PRVA | Privia Health | 3.23 | ||||
PINC | Premier | 1.97 | ||||
HSTM | HealthStream | 1.56 | ||||
GKOS | Glaukos Corp | 1.18 | ||||
ITGR | Integer Holdings | 0.55 | ||||
SGRY | Surgery Partners | 0.09 | ||||
HQY | HealthEquity | 0.13 |
Complementary Tools for Evolent Stock analysis
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |